Renocel IU Injection

Renocel 4000 IU Injection is a recombinant human erythropoietin alfa therapy designed to stimulate red blood cell production in patients suffering from anemia. It is widely prescribed for anemia caused by chronic kidney disease, cancer chemotherapy, and HIV treatment. By improving hemoglobin levels, Renocel 4000 helps reduce the need for frequent blood transfusions, enhances oxygen supply to tissues, and supports patient recovery. The injection is administered under medical supervision via subcutaneous or intravenous routes.

Key Benefits

• Restores red blood cell count and improves hemoglobin levels.
• Reduces fatigue and enhances quality of life in anemic patients.
• Lowers dependency on blood transfusions, easing caregiver burden.
• Supports cardiovascular stability and reduces anemia-related complications.
• Improves adherence to primary therapies by enhancing patient resilience.

Therapeutic Indications

• Chemotherapy-induced anemia
• Chronic kidney disease